PolyModels Hub has raised £7 million in a Series A round to accelerate the digital transformation of biopharma process development.

The London firm said the funding will enable it to expand its engineering and product teams and reach more pharmaceutical organisations worldwide.

Developing a new drug typically costs around $2.5 billion, with roughly a quarter of that — about $650 million — spent on process development alone. Across the hundreds of therapies progressing through the pipeline each year, this represents a vast opportunity to make drug development faster, more efficient, and more reproducible.

The Polymodels Hub platform, ModelFlow, brings together advanced modeling, simulation and workflow management in one place. It allows scientists and engineers to design, test and refine manufacturing processes faster.